PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications.
about
Molecular Imaging-Guided Interventional Hyperthermia in Treatment of Breast Cancer.Magnetic Nanoparticles in Cancer TheranosticsSurface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer.Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.Manganese-loaded lipid-micellar theranostics for simultaneous drug and gene delivery to lungsProgress on the diagnosis and evaluation of brain tumors.Theranostic Magnetic Nanostructures (MNS) for Cancer.Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy.Nanoways to overcome docetaxel resistance in prostate cancer.Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapyAssessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma.Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticlesImplications of protein corona on physico-chemical and biological properties of magnetic nanoparticles.Cancer theranostics: the rise of targeted magnetic nanoparticles.Interaction of curcumin nanoformulations with human plasma proteins and erythrocytesCurcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications.Therapeutic Applications of Curcumin NanoformulationsCurcumin nanomedicine: a road to cancer therapeuticsDual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseasesUptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cellsNovel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatmentBiological applications of magnetic nanoparticles.Applications and potential toxicity of magnetic iron oxide nanoparticles.Magnetoliposomes and their potential in the intelligent drug-delivery field.Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer.Targeted drug delivery to the brain using magnetic nanoparticles.Magnetic nanoformulations for prostate cancer.MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer modelThe role of magnetic nanoparticles in the localization and treatment of breast cancerSynthesis and characterization of smart N-isopropylacrylamide-based magnetic nanocomposites containing doxorubicin anti-cancer drug.Synthesis and Characterization of the First Generation of Polyamino-Ester Dendrimer-Grafted Magnetite Nanoparticles from 3-Aminopropyltriethoxysilane (APTES) via the Convergent ApproachMulti-stimuli-responsive magnetic assemblies as tunable releasing carriersEffect of the Molecular Weight of Poly(ethylene glycol) on the Properties of Biocompatible Magnetic FluidsPreparation and Characterisation of Highly Stable Iron Oxide Nanoparticles for Magnetic Resonance Imaging
P2860
Q26780500-345FF26C-CE1B-4410-9BD2-2AA770367F8EQ26784379-9C7CE922-FB14-434F-B3E4-BEFBECBCDB7CQ30439353-5D979AFB-C05A-4B6F-B831-CEA60B51FEBEQ30466992-517B76C4-80BB-4ED0-9892-0F4EC933720BQ30587526-0B82EDA6-CF76-4686-BC38-5B4F2955E368Q30714285-99B2BA15-99DA-4C1B-8CAA-B7D6C1293FD0Q30937214-7ACC306D-3110-47FA-A5DA-57BFE86B734CQ33774864-2BA03332-D754-4876-958D-C5D31C7EC7A1Q33909084-0AF3B48E-91DA-463C-8532-94072BAA070CQ34110096-A7934507-51B1-4198-851E-0094B89C6CC3Q34287136-BC00333F-1F4D-49EF-90CD-7C2F4B46DAB6Q34500552-FD447FB2-B413-4EBF-8CAF-DA3C91739966Q34701443-2C0040AB-5400-4EAB-AA47-6045F9D53720Q35343983-0F2ECCC6-02DA-49CE-A361-07AA6F395FD7Q35533813-12D00E24-2717-4454-AE71-5426884899D1Q35576287-1AB8E572-060D-4F14-891B-547CFBABF19DQ35972616-11B3807F-D1FB-4CB0-98CB-F7C59E03F97CQ36232513-2F89F6EA-F5B6-4FBE-9894-738A6DAA6C29Q36807261-9D9B5D4B-A681-4AEF-BC67-BFDEB4405760Q37078082-221162FD-7413-4A6B-B678-A3E6B7E7E34CQ37235640-CDC88183-2345-4E97-B2AF-D390978429DFQ37662418-5E4C2BF6-A931-41BD-B0EB-691C7990904AQ38000520-3EE13948-9748-4E59-A3D6-410C0A46CBA4Q38047272-DF000AA7-7A47-4BAE-8ADB-0104E28DB5E7Q38074445-9F6C5402-82DC-410F-B558-51E2B9C0A560Q38115981-6DE73B8B-D87A-4C25-9F4F-57487E9A0733Q38601774-C7BC9E30-8FC5-4E34-B2F2-182FD50D26E6Q39319113-3BAE98B4-2C34-4D18-BF11-4D5FF8114D78Q39433320-0A42B3B1-5C8A-43F9-AB5A-C78C4E13EE42Q42031750-235AB003-7577-409D-8BDD-021BC7676412Q53098199-EBA1DBFF-FB1A-4F42-AB8B-8E385ADEE71DQ57353222-6376F54B-0798-4EE2-A081-312A9C09BB54Q57366857-EEC60616-C045-4133-8B06-BDCB7F07C1ACQ58801001-E82C2496-08D5-499B-A615-F1EEB54B7196Q59146776-AF8996D4-9D25-4F1E-87D4-3249A4AB7C9F
P2860
PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
PEG-functionalized magnetic na ...... esonance imaging applications.
@ast
PEG-functionalized magnetic na ...... esonance imaging applications.
@en
type
label
PEG-functionalized magnetic na ...... esonance imaging applications.
@ast
PEG-functionalized magnetic na ...... esonance imaging applications.
@en
prefLabel
PEG-functionalized magnetic na ...... esonance imaging applications.
@ast
PEG-functionalized magnetic na ...... esonance imaging applications.
@en
P2093
P2860
P921
P1476
PEG-functionalized magnetic na ...... esonance imaging applications.
@en
P2093
Murali Mohan Yallapu
Susan P Foy
Tapan K Jain
Vinod Labhasetwar
P2860
P304
P356
10.1007/S11095-010-0260-1
P577
2010-09-16T00:00:00Z